Adipose Inflammation and Diabetes (FAB)
Recruiting
- Conditions
- Obese
- Registration Number
- NCT04255264
- Lead Sponsor
- Göteborg University
- Brief Summary
The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
- BMI 30-40 kg/m2
- Ptos (i.e. excess skin) > 3 cm
- Patient underwent gastric bypass surgery >2 years ago
- Patient has had a stable weight ≥6 months at the time of operation
- Patient does not smoke (min 6 weeks prior to surgery)
Exclusion Criteria
- Patients who do not understand spoken and written Swedish
- American Society of Anesthesiologists (ASA) classification ≥ 3
- Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
- Preoperatively known hernia requiring surgical operation
- Severe mental illness
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory status 2025 The inflammatory status will be studied in obese patients.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sahlgrenska university hospital
🇸🇪Gothenburg, Vastra Gotaland, Sweden